BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Acadia Pharmaceuticals
ACAD
$4.88B
| $1.53M | ﹤0.01% |
35,716
-11,467
| -24% | -$499K |
|
1727
CALL
Waste Management
WM
$90B
| $1.53M | ﹤0.01% |
134
-127
| -49% | -$14.3K |
|
1728
Allegion
ALLE
$14B
| $1.53M | ﹤0.01% |
12,259
-16,110
| -57% | -$1.86M |
|
1729
CALL
Arista Networks
ANET
$251B
| $1.53M | ﹤0.01% |
+1,200
| New | +$15.8K |
|
1730
PUT
Monster Beverage
MNST
$91.2B
| $1.53M | ﹤0.01% |
960
+416
| +76% | +$6.11K |
|
1731
iShares MSCI China ETF
MCHI
$6.16B
| $1.52M | ﹤0.01% |
23,779
-1,440,490
| -98% | -$86.2M |
|
1732
Adeia
ADEA
$3.31B
| $1.52M | ﹤0.01% |
311,098
+178,923
| +135% | +$950K |
|
|
VMW
1733
PUT
DELISTED
VMware, Inc
VMW
| $1.52M | ﹤0.01% |
100
| – | – |
|
1734
CALL
Ross Stores
ROST
$78.4B
| $1.51M | ﹤0.01% |
130
| – | – |
|
|
1735
PUT
Ross Stores
ROST
$78.4B
| $1.51M | ﹤0.01% |
130
| – | – |
|
|
ONC
1736
BeOne Medicines Ltd
ONC
$39.3B
| $1.51M | ﹤0.01% |
9,127
-5,327
| -37% | -$885K |
|
|
AMED
1737
DELISTED
Amedisys
AMED
| $1.51M | ﹤0.01% |
9,052
+1,675
| +23% | +$249K |
|
1738
Timken Company
TKR
$9.23B
| $1.51M | ﹤0.01% |
26,821
+9,217
| +52% | +$466K |
|
1739
Orthofix Medical
OFIX
$420M
| $1.51M | ﹤0.01% |
32,693
+28,939
| +771% | +$1.36M |
|
|
SAGE
1740
DELISTED
Sage Therapeutics
SAGE
| $1.5M | ﹤0.01% |
20,837
+15,609
| +299% | +$1.92M |
|
1741
PUT
Alerian MLP ETF
AMLP
$13.2B
| $1.5M | ﹤0.01% |
+354
| New | +$14.9K |
|
|
DRNA
1742
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.5M | ﹤0.01% |
68,100
+59,685
| +709% | +$1.2M |
|
1743
SLM Corp
SLM
$5.23B
| $1.49M | ﹤0.01% |
167,738
-1,385,454
| -89% | -$12M |
|
1744
Insperity
NSP
$2B
| $1.49M | ﹤0.01% |
17,369
+9,955
| +134% | +$866K |
|
|
PRFT
1745
DELISTED
Perficient Inc
PRFT
| $1.49M | ﹤0.01% |
32,343
+27,206
| +530% | +$1.11M |
|
1746
Arrowhead Research
ARWR
$12.3B
| $1.49M | ﹤0.01% |
23,414
+5,725
| +32% | +$284K |
|
1747
SM Energy
SM
$8.03B
| $1.48M | ﹤0.01% |
131,969
+50,752
| +62% | +$457K |
|
1748
American Homes 4 Rent
AMH
$12.3B
| $1.48M | ﹤0.01% |
56,460
-71,815
| -56% | -$1.87M |
|
|
QVCGA
1749
DELISTED
QVC Group Inc Series A
QVCGA
| $1.48M | ﹤0.01% |
3,609
-1,039
| -22% | -$468K |
|
1750
The GEO Group
GEO
$4.03B
| $1.47M | ﹤0.01% |
88,535
+54,322
| +159% | +$825K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.